相似文献
1
Targeted therapies for killing tumor cells.
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10028-30. doi: 10.1073/pnas.191379998.
2
A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells.
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10332-7. doi: 10.1073/pnas.171315198.
3
Intraperitoneal injection of adenovirus expressing antisense K-ras RNA suppresses peritoneal dissemination of hamster syngeneic pancreatic cancer without systemic toxicity.
Cancer Lett. 2005 Jan 31;218(1):53-62. doi: 10.1016/j.canlet.2004.08.015.
4
Interferon-alpha and antisense K-ras RNA combination gene therapy against pancreatic cancer.
J Gene Med. 2004 Oct;6(10):1139-48. doi: 10.1002/jgm.602.
5
Molecular target-based therapy of pancreatic cancer.
Cancer Res. 2006 Feb 15;66(4):2403-13. doi: 10.1158/0008-5472.CAN-05-3510.
6
Trials of gene therapy for pancreatic carcinoma.
Curr Gastroenterol Rep. 2005 Jun;7(3):165-9. doi: 10.1007/s11894-005-0028-7.
7
[Recent advances in gene change of pancreatic cancer].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Feb;26(1):79-82.
8
Inhibition of pancreatic cancer cell growth in vivo using a tetracycline-inducible cyclin D1 antisense expression system.
Pancreas. 2013 Jan;42(1):141-8. doi: 10.1097/MPA.0b013e3182546de5.
9
[Molecular mechanism in pancreatic carcinogenesis: Ras gene].
Nihon Rinsho. 2006 Jan;64 Suppl 1:32-5.
10
Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro.
Gene Ther. 2000 Dec;7(23):2051-7. doi: 10.1038/sj.gt.3301330.
引用本文的文献
1
Self-assembled micelles loaded with itraconazole as anti-Acanthamoeba nano-formulation.
Arch Microbiol. 2024 Mar 4;206(4):134. doi: 10.1007/s00203-024-03854-3.
2
mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine.
Pharmacol Ther. 2006 Sep;111(3):596-628. doi: 10.1016/j.pharmthera.2005.11.005. Epub 2006 Feb 7.
3
Herpes simplex virus thymidine kinase and ganciclovir suicide gene therapy for human pancreatic cancer.
World J Gastroenterol. 2004 Feb 1;10(3):400-3. doi: 10.3748/wjg.v10.i3.400.
4
Experimental animal models of pancreatic carcinogenesis and metastasis.
Int J Gastrointest Cancer. 2003;33(1):43-60. doi: 10.1385/IJGC:33:1:43.
本文引用的文献
1
A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells.
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10332-7. doi: 10.1073/pnas.171315198.
2
Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials.
Semin Oncol. 2001 Feb;28(1 Suppl 3):13-9. doi: 10.1016/s0093-7754(01)90188-5.
3
Ras biochemistry and farnesyl transferase inhibitors: a literature survey.
Anticancer Drugs. 2001 Mar;12(3):163-84. doi: 10.1097/00001813-200103000-00001.
4
Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer.
Cancer Res. 2001 Mar 15;61(6):2562-71.
5
The potential role of antivascular therapy in the adjuvant and neoadjuvant treatment of cancer.
Semin Oncol. 2001 Feb;28(1):93-105. doi: 10.1016/s0093-7754(01)90047-8.
6
Integrin antagonists.
Cell Mol Life Sci. 1999 Oct 30;56(5-6):427-41. doi: 10.1007/s000180050443.
7
Telomerase inhibitors.
Trends Biotechnol. 2001 Mar;19(3):114-20. doi: 10.1016/s0167-7799(00)01541-9.
8
New aspects of integrin signaling in cancer.
Semin Cancer Biol. 2000 Dec;10(6):407-14. doi: 10.1006/scbi.2000.0337.
9
Gene replacement strategies for treating non-small cell lung cancer.
Semin Radiat Oncol. 2000 Oct;10(4):333-42. doi: 10.1053/srao.2000.9127.
10
Inhibition of ras oncogene: a novel approach to antineoplastic therapy.
J Biomed Sci. 2000 Jul-Aug;7(4):292-8. doi: 10.1007/BF02253247.
Zotero 插件